BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24225251)

  • 21. [Prognostic value of toxicities induced by targeted therapies in patients treated for a metastatic renal cell carcinoma].
    Nouhaud FX; Rebibo JD; Blanchard F; Sabourin JC; Di Fiore F; Pfister C
    Prog Urol; 2014 Jul; 24(9):563-71. PubMed ID: 24975791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
    Rose TL; Deal AM; Krishnan B; Nielsen ME; Smith AB; Kim WY; Milowsky MI
    Cancer; 2016 Oct; 122(19):2988-95. PubMed ID: 27341404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brazilian data of renal cell carcinoma in a public university hospital.
    Aguiar P; Padua TC; Guimaraes DP
    Int Braz J Urol; 2016; 42(1):29-36. PubMed ID: 27136465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy for Brain Metastases From Renal Cell Carcinoma in the Targeted Therapy Era: The University of Rochester Experience.
    Bates JE; Youn P; Peterson CR; Usuki KY; Walter KA; Okunieff P; Milano MT
    Am J Clin Oncol; 2017 Oct; 40(5):439-443. PubMed ID: 25730604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy.
    Kawano Y; Takahashi W; Eto M; Kamba T; Miyake H; Fujisawa M; Kamai T; Uemura H; Tsukamoto T; Azuma H; Matsubara A; Nishimura K; Nakamura T; Ogawa O; Naito S
    Cancer Sci; 2016 Jul; 107(7):1013-7. PubMed ID: 27089226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis.
    Vogelzang NJ; Pal SK; Ghate SR; Swallow E; Li N; Peeples M; Zichlin ML; Meiselbach MK; Perez JR; Agarwal N
    Adv Ther; 2017 Nov; 34(11):2452-2465. PubMed ID: 29076108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.
    Guram K; Huang J; Mouchati C; Abdallah N; Jani C; Navani V; Xie W; El Zarif T; Adib E; Gebrael G; Agarwal N; Li H; Labaki C; Labban M; Ruiz Morales JM; Choueiri TK; Chin Heng DY; Mittal A; Hansen AR; Rose BS; McKay RR
    Cancer; 2024 Jun; 130(11):2003-2013. PubMed ID: 38297953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Nephrectomy for Kidney Cancer in the Era of Targeted and Immune Therapies.
    Vaishampayan UN
    Am Soc Clin Oncol Educ Book; 2016; 35():e16-20. PubMed ID: 27249719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoreductive Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy Era.
    Uprety D; Bista A; Smith AL; Vallatharasu Y; Marinier DE
    Anticancer Res; 2018 May; 38(5):3013-3018. PubMed ID: 29715133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis.
    Tsao CK; Small AC; Kates M; Moshier EL; Wisnivesky JP; Gartrell BA; Sonpavde G; Godbold JH; Palese MA; Hall SJ; Oh WK; Galsky MD
    World J Urol; 2013 Dec; 31(6):1535-9. PubMed ID: 23223962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of cytoreductive nephrectomy in renal cell carcinoma patients with liver metastasis.
    Guo B; Liu S; Wang M; Hou H; Liu M
    Bosn J Basic Med Sci; 2021 Apr; 21(2):229-234. PubMed ID: 32767963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC).
    Aizer AA; Urun Y; McKay RR; Kibel AS; Nguyen PL; Choueiri TK
    BJU Int; 2014 May; 113(5b):E67-74. PubMed ID: 24053727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and prognostic factors of patients with renal cell cancer with bone metastasis in the era of targeted therapy: A single-institution analysis.
    Du Y; Pahernik S; Hadaschik B; Teber D; Duensing S; Jäger D; Hohenfellner M; Grüllich C
    Urol Oncol; 2016 Oct; 34(10):433.e1-8. PubMed ID: 27321354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal cell carcinoma in young patients is associated with poorer prognosis.
    Lee LS; Yuen JS; Sim HG
    Ann Acad Med Singap; 2011 Sep; 40(9):401-6. PubMed ID: 22065033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Effectiveness of Initial Surgery vs Initial Systemic Therapy for Metastatic Kidney Cancer in the Targeted Therapy Era: Analysis of a Population-based Cohort.
    Macleod LC; Odisho AY; Tykodi SS; Holt SK; Harper JD; Gore JL
    Urology; 2018 Mar; 113():146-152. PubMed ID: 29174942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study.
    Eminaga O; Akbarov I; Wille S; Engelmann U
    Int Urol Nephrol; 2015 Oct; 47(10):1653-63. PubMed ID: 26329746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Perioperative Infection on Cancer Specific Survival after Nephrectomy for Renal Cell Carcinoma.
    Tallman JE; Pearce SM; Kuchta K; Helfand BT; Eggener SE
    J Urol; 2017 Nov; 198(5):1027-1032. PubMed ID: 28551443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras.
    Keskin SK; Msaouel P; Hess KR; Yu KJ; Matin SF; Sircar K; Tamboli P; Jonasch E; Wood CG; Karam JA; Tannir NM
    J Urol; 2017 Sep; 198(3):530-537. PubMed ID: 28411072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database.
    Poprach A; Bortlíček Z; Büchler T; Melichar B; Lakomý R; Vyzula R; Brabec P; Svoboda M; Dušek L; Gregor J
    Med Oncol; 2012 Dec; 29(5):3314-20. PubMed ID: 22752571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
    de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
    Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.